Mabano, Concepcion P.
HRN: 20-30-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2022
CEFTAZIDIME 1GM (VIAL)
04/24/2022
05/01/2022
IVT
1g
Q8
SEPSIS WBC 30.4
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstreamSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes